Newsletter
| Promoter: | AwesomeStockPick | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| PXYN | No compensation | UNKNOWN |
| Max Profit: 23.75 % | Gain at close: 0.00 % | |
| *We think that this promoter is a part of a group of promoters. | ||
| Members, its important to ADD us to your Email Contact List so you can beat the crowd and get our Awesome Picks sent directly to your Inbox. You can unsubscribe below at any time but you will no longer get our Awesome Wall Street Picks. PXYN - Time is Running Out! Warning, what your about to read contains monster upside potential and has been trading extremely undervalued. You have been warned! Bottom is in & in the Verge of a Breakout! PXYN looks to have been accumulating between the .05 to .056 cent range since last week and we are looking at a strong potential launch from all this coiling. Currently trading in the low .05 cent range, we feel that PXYN is way undervalued and its up-potential has been growing more by the week. (Coiled & Ready Chart) PXYN Now Licensed to Dispense Medication in Twelve States PXYN, announced last week that its subsidiary, Mesa Pharmacy Inc., is making progress towards its goal of dispensing its customized medications nationwide. PXYN is now licensed to dispense its medications in the following states: Arizona, California, Florida, Hawaii, Illinois, Indiana, Nevada, New Mexico, Oklahoma, Texas, Washington, Wisconsin (Praxsyn Now Licensed to Dispense Medication in Twelve States) PXYN Must See Recent 10-Q Report PXYN 10-Q report released in July indicates that PXYN is clearly undervalued at its current trading range. PXYN 10-Q showed roughly 800% revenues and roughly150% increase from its Q1's report. (SEC form 10-Q, Quarterly Report) About PXYN
PXYN (Praxyn Corporation) is a health care company dedicated to providing medical practitioners with medications and services for their patients. PXYN facility in Irvine, California currently formulate transdermal creams using therapeutic and preventative agents for pain management. PXYN products are geared to patients suffering from long-term pain associated with work place related injuries. PXYN operations consist of the production and sale, by prescription, of its pain management products to California workers' compensation insurance providers. PXYN products are shipped directly to patients, and billings for these products are typically made to and collected from the insurance providers of the patients' employers. PXYN website for info: (www.praxsyn.com)
|
|
|
 |
|
Members, please make sure to White-list us now by adding our sender name AwesomeStockPick and sender email address info@awesomestockpick.com to your contact list (address book) or safe sender list. Add us now to ensure you get our AwesomeStockPick's sent directly to your email inbox and not your spam box. Remember, timing is everything in the markets and that's why its important to add us now.
Your Team, AwesomeStockPick GENERAL NOTICE AND DISCLAIMER (Please read carefully): We are engaged in the business of advertising and marketing companies for monetary compensation. By viewing or using AwesomeStockPick.com (hereafter referred to as "ASP") you hereby fully agree to our Legal Disclaimer & Disclosure (http://awesomestockpick.com/disclaimer ) and our Privacy Policy. This is not a solicitation to buy or sell a security. This is for entertainment purposes only. Never invest into a stock discussed on our website or the ASP newsletter unless you can afford to lose your entire investment. ASP is not a registered broker dealer or a registered investment advisor. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. Please consult with a certified financial advisor before making any investment decisions. This is sponsored advertising and does not purport to provide an analysis of the featured company's financial position, operations or prospects and is not to be construed as a recommendation or solicitation by ASP, to buy or sell any security in any jurisdiction. The information contained herein is based on sources that ASP believes to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. ASP encourages readers and investors to supplement the information in this report with independent research and other professional advice. All information on the featured company is provided by the company profiled, or is available from public sources and ASP makes no representations or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this report are statements of judgment as of the date of publication and are subject to change without further notice and may not necessarily be reprinted in future publications or elsewhere. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the company profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead ASP strongly urges you to conduct a complete and independent investigation of the respective companies. ASP does not offer such advice or analysis and ASP further urges you to consult your own independent tax, business, financial and investment advisors. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the company profiled. ASP, its operators, owners, employees, and affiliates may have interests or positions in equity securities of the companies profiled by ASP, some or all of which may have been acquired prior to the dissemination of this report and may increase or decrease these positions at any time. This report may contain forward-looking-statements, which involve risks and uncertainties. Accordingly no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward statement. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking-statements made by ASP about the company profiled. If applicable investors are also directed to consider other risks and uncertainties discussed in documents filed by the profiled company with the Securities and Exchange Commission. ASP undertakes no obligation to publicly release the result of any revisions to these forward-looking-statements which may be made to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events. Notice of Stock Price Volatility and Movements: Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week. Third Party Advertising Agency/Advertiser: ASP has not been compensated from a third party non affiliate for investor communications services on Praxsyn Corp., (PXYN) (hereafter referred to as "PXYN"). ASP does not expect to be compensated for this alert. ASP receives this compensation as a production budget for advertising efforts and will retain amounts over and above the cost of production, copy-writing services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding this new profile. When compensation for a production budget for its marketing and advertising efforts are retained, ASP will disclose any future compensation if such compensation occurs. In future, ASP will disclose any and all further and future compensation. Some of the services performed have or may include profiling this new profile on the ASP website and issuing opinions concerning this new profile in newsletters. Anyone viewing the ASP website or its newsletters should assume the hiring party or affiliates of the hiring party own shares of this new profile, which they plan to liquidate. Further, it must be understood that the liquidation of those shares may or may not negatively impact the share price. ASP, the third party advertiser, has represented that it is not a current shareholder of this new profile and that it does not buy or sell any shares in this new profile during the period that this advertisement is being disseminated. |
364 E Main St #724
Middletown, DE, 19709
United States